Chandran Remya

This study identifies novel Cdk5 inhibitors that improve T2D symptoms and cognitive function in a mouse model.

This study investigates benzamidine's inhibition of human lysozyme aggregation, showing it prevents amyloid formation and alters fibril morphology without cytotoxicity.

This study improves pose prediction accuracy in molecular docking by incorporating symmetry-related molecules, showing better prediction of biologically relevant poses.

The paper designs, synthesizes, and evaluates neuroprotective derivatives of tacrine that target both acetylcholinesterase and NMDA receptors, showing reduced hepatotoxicity and potential therapeutic benefits.